Literature DB >> 11443508

Relationship of obesity distribution and peripheral arterial occlusive disease in elderly men.

A Planas1, A Clará, J M Pou, F Vidal-Barraquer, A Gasol, A de Moner, C Contreras, J Marrugat.   

Abstract

OBJECTIVE: To examine the relationships between total body fatness and abdominal fat distribution with peripheral arterial disease.
DESIGN: Cross-sectional.
SUBJECTS: Population-based sample of 708 men aged 55-74. MEASUREMENTS: Body mass index (BMI) to estimate total body fatness and waist-to-hip ratio for abdominal fat distribution; peripheral arterial disease defined by ankle/brachial index <0.9; cardiovascular risk factors.
RESULTS: Peripheral arterial disease was observed in 13.4% of subjects. BMI did not correlate with peripheral arterial disease, whereas an increased waist-to-hip ratio over 0.966 (median value) doubled the prevalence of arterial disease. After controlling for smoking, diabetes, hypertension, high-density lipoprotein cholesterol and triglycerides, increased waist-to-hip ratio was independently associated with peripheral arterial disease (odds ratio 1.68; 95% confidence interval 1.05-2.70).
CONCLUSION: Abdominal fat distribution, but not total body fatness, is associated with peripheral arterial occlusive disease, independently of concurrent cardiovascular risk factors.

Entities:  

Mesh:

Year:  2001        PMID: 11443508     DOI: 10.1038/sj.ijo.0801638

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  17 in total

1.  High-sensitivity C-reactive protein and ankle brachial index in a finnish cardiovascular risk population.

Authors:  K Syvänen; P Korhonen; P Jaatinen; T Vahlberg; P Aarnio
Journal:  Int J Angiol       Date:  2011-03

2.  Association between lifestyles, anthropometric measurements and peripheral arterial disease in public sector health workers.

Authors:  Janett V Chávez-Sosa; Ricardo Rojas-Humpire; Rosmery Gutierrez-Ajalcriña; Salomón Huancahuire-Vega
Journal:  Am J Cardiovasc Dis       Date:  2021-04-15

3.  Incidence and risk factors of peripheral arterial occlusive disease in a prospective cohort of 700 adult elderly men followed for 5 years.

Authors:  Jana Merino; Adriana Planas; Roberto Elosua; Ana de Moner; Ana Gasol; Carmen Contreras; Francesc Vidal-Barraquer; Albert Clarà
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

4.  Periaortic fat deposition is associated with peripheral arterial disease: the Framingham heart study.

Authors:  Caroline S Fox; Joseph M Massaro; Christopher L Schlett; Sam J Lehman; James B Meigs; Christopher J O'Donnell; Udo Hoffmann; Joanne M Murabito
Journal:  Circ Cardiovasc Imaging       Date:  2010-07-16       Impact factor: 7.792

5.  Association of Body Mass Index With Infectious Complications in Free Tissue Transfer for Head and Neck Reconstructive Surgery.

Authors:  Mohemmed N Khan; Jack Russo; John Spivack; Christopher Pool; Ilya Likhterov; Marita Teng; Eric M Genden; Brett A Miles
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-06-01       Impact factor: 6.223

Review 6.  Evidence-based management of peripheral vascular disease.

Authors:  Nicolas W Shammas; Eric J Dippel
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

Review 7.  The role of nutrition and body composition in peripheral arterial disease.

Authors:  Diana P Brostow; Alan T Hirsch; Tracie C Collins; Mindy S Kurzer
Journal:  Nat Rev Cardiol       Date:  2012-08-28       Impact factor: 32.419

Review 8.  Exercise training and peripheral arterial disease.

Authors:  Tara L Haas; Pamela G Lloyd; Hsiao-Tung Yang; Ronald L Terjung
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

9.  Abdominal obesity is associated with peripheral artery disease in hemodialysis patients.

Authors:  Peir-Haur Hung; Hung-Bin Tsai; Chien-Hung Lin; Kuan-Yu Hung
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

Review 10.  Epidemiology, classification, and modifiable risk factors of peripheral arterial disease.

Authors:  Nicolas W Shammas
Journal:  Vasc Health Risk Manag       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.